TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · major macro event coming up
LNSR

LENSAR Inc

Healthcare · Medical Devices

5.60$ -1.8% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns LENSAR Inc (LNSR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.0% of the shares are freely tradable; institutional investors hold 52.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 52.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 21.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 12Mio.

Largest Shareholders

Institutions

Institutions LNSR
Name Stake (%) Shares Change (%) Date
Brandes Investment Partners & Co 8.75 1,075,400 +4.9 06/30/2026
Vanguard Capital Management, LLC 3.28 402,806 +3.3 06/30/2026
RBF LLC 1.54 188,661 +314.4 06/30/2026
BlackRock Inc 1.51 185,033 -70.6 06/30/2026
Css LLC 1.33 163,450 +0.0 06/30/2026
Dimensional Fund Advisors, Inc. 1.23 151,609 -32.6 06/30/2026
Kerrisdale Advisers, LLC 1.13 139,390 +0.0 06/30/2026
Millennium Management LLC 0.98 120,680 +860.4 06/30/2026

Funds

Funds LNSR
Name Stake (%) Shares Change (%) Date
Brandes Small Cap Value R6 5.81 714,261 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.25 275,971 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?